Delivery Order SPE2DB22D1106-SPE2DB23FEVW0
Award Date 8/17/23
Potential Completion Date 8/18/23
Potential Value $11K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $41,865.81 to Amerisourcebergen Drug Corporation for the supply of 4561742228 REXULTI 1 MG TABLET 30S. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation and will perform under the contract from its place of performance in Conshohocken, Pennsylvania. The contract period of performance spans from August 8, 2023 through August 9, 2023. No major subcontractors or...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $14,000 to Amerisourcebergen Drug Corporation. The order is for 30 tablets of REXULTI 2 MG to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unknown location by July 19, 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will perform as the prime contractor. The Defense Logistics Agency will provide funding for this order...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,635.97 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 4561541571 REXULTI 2 MG TABLETS (30 count) to be delivered to a facility located in Conshohocken, Pennsylvania by July 13, 2023. The Defense Logistics Agency is the logistics combat support agency for the United States Department of Defense, charged with procuring and providing logistics support for multiple...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $6,752 to Amerisourcebergen Drug Corporation. The order is for 30 tablets of REXULTI 4 MG to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 1, 2023 in support of the Defense Logistics Agency's logistics and procurement programs. Amerisourcebergen Corporation is the identified parent company for Amerisourcebergen Drug Corporation, the prime contractor performing...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $8,666.20 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 4562015618 REXULTI 4 MG TABLET 30S to the agency. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania, spanning from August 31, 2023 through September 1, 2023. As a prime contractor supporting the Defense Logistics Agency's medical supply needs, Amerisourcebergen will deliver...
- The Defense Logistics Agency awarded a $8,196.02 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 units of 2 mg REXULTI tablets. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products to various Department of Defense components. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania by July 24, 2023 to support the DLA's medical supply needs. No set aside designation or...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $8,726 to Amerisourcebergen Drug Corporation. The order is for 30 packs of 1 mg REXULTI tablets to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 7, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. No subcontractors or set aside designations were identified. The Defense...
- The Defense Logistics Agency Troop Support Medical awarded a $25,520.87 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4561568343 REXULTI 1 MG TABLET 30S. The place of performance is Conshohocken, Pennsylvania. The period of performance is July 21, 2023 through July 24, 2023. No major subcontractors or set aside designations were identified. This delivery order was issued under an existing indefinite-delivery/indefinite-quantity contract vehicle to...
- <p>The Defense Logistics Agency awarded a $4,344 delivery order to Amerisourcebergen Drug Corporation for 30 boxes of 2 mg REXULTI tablets. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania through August 7, 2023 in support of the Defense Logistics Agency's pharmaceutical procurement programs. No subcontractors or set aside designations were identified.</p>
- The Defense Logistics Agency awarded a $8,942 delivery order to Amerisourcebergen Drug Corporation for 30 boxes of 1 mg REXULTI tablets each containing 30 pills under firm fixed price terms. The order is to be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by August 7, 2023 to support the Defense Logistics Agency's medical supply needs. No set aside designation or subcontractors were identified. The Defense Logistics Agency manages the global supply chain for...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB23FEVW0Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,572 to Amerisourcebergen Drug Corporation to supply 4561853545 REXULTI 1 MG TABLET 30S. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation and will perform under the contract from its location in Conshohocken, Pennsylvania. Funding is provided by the Defense Logistics Agency to support its logistics and procurement programs. No subcontractors or set aside designations were identified. The single delivery order is for a specific pharmaceutical product and has a period of performance from August 17 to August 18, 2023.
Generated 12/22/23, 10:05 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 8/17/23 |